Atlas Trials

Phase I/II Study to a Assess the GBS-06 Vaccine Manufactured by Inventprise, Inc., in Healthy, Non-Pregnant, Adult Women of Childbearing Age.

Clinical trial NCT06611371 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06611371
Sponsor
Inventprise Inc.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Group B Streptococcal Infections
Start date
2024-11-12
Primary completion
2025-08-26
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.